CIS Pharma starts collaboration with the Paul Scherer Institute on antibody-radionuclide conjugates
Bubendorf, Switzerland, Thursday, November 22, 2018 - CIS Pharma has identified the group of Prof. Schibli and Dr. Behe from the Paul Scherer Institute, ETH, as potential partners for its [...]